Tatarstan Cancer Center
2 clinical trials · Sponsor
◉ Watch Tatarstan Cancer Center
| Record | Firm | Date |
|---|---|---|
| Moderately Hypofractionated Radiotherapy for Prostate Cancer. (NCT03827616) | Tatarstan Cancer Center | 2019-01-25 |
| Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer (NCT03495544) | Tatarstan Cancer Center | 2018-01-01 |
Track Tatarstan Cancer Center automatically
Every clearance here is in the API, with alerts when new ones post.